These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Hepatitis B antigen: new technics for the reduction of posttransfusion hepatitis. Gitnick GL; Koretz RL Am J Gastroenterol; 1974 May; 61(5):366-70. PubMed ID: 4835933 [No Abstract] [Full Text] [Related]
27. A random controlled study of the prophylactic effect of lysozyme chloride on post-transfusion hepatitis. Sato M; Oe H; Nakano M; Kawasaki H; Hirayama C Hepatogastroenterology; 1981 Jun; 28(3):135-8. PubMed ID: 7019033 [TBL] [Abstract][Full Text] [Related]
28. [Hepatitis: an international problem (author's transl)]. Deinhardt F MMW Munch Med Wochenschr; 1976 Aug; 118(35):1085-92. PubMed ID: 60698 [TBL] [Abstract][Full Text] [Related]
29. [On the prophylaxis and therapy with human immune globulin preparations]. Hässig A Bibl Haematol; 1967; 27():239-52. PubMed ID: 4174429 [No Abstract] [Full Text] [Related]
30. Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. A controlled study. Kleinknecht D; Courouce AM; Delons S; Naret C; Adhemar JP; Ciancioni C; Fermanian J Clin Nephrol; 1977 Sep; 8(3):373-6. PubMed ID: 912951 [TBL] [Abstract][Full Text] [Related]
31. Post-transfusion hepatitis: the role of hepatitis B antibody. Koretz RL; Overby LR; Gitnick GL Gastroenterology; 1976 Apr; 70(4):556-61. PubMed ID: 56285 [TBL] [Abstract][Full Text] [Related]
32. Endemic viral hepatitis in U.S. soldiers: causative factors and the effect of prophylactic gamma globulin. Conrad ME Can Med Assoc J; 1972 Feb; 106(Spec Issue):Suppl:456-60. PubMed ID: 4111525 [No Abstract] [Full Text] [Related]
33. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus. Nair PV; Weissman JY; Tong MJ; Thursby MW; Paul RH; Henneman CE Gastroenterology; 1984 Aug; 87(2):293-8. PubMed ID: 6376265 [TBL] [Abstract][Full Text] [Related]
34. [Problems in post-transfusion hepatitis]. Fiedler H Munch Med Wochenschr; 1972 Mar; 114(12):549-52. PubMed ID: 5067649 [No Abstract] [Full Text] [Related]
35. [Serum hepatitis from the viewpoint of Au-SH antigen studies]. Wewalka F Bibl Haematol; 1971; 37():235-42. PubMed ID: 5138909 [No Abstract] [Full Text] [Related]
36. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Knodell RG; Conrad ME; Ishak KG Gastroenterology; 1977 May; 72(5 Pt 1):902-9. PubMed ID: 66167 [TBL] [Abstract][Full Text] [Related]
37. The preparation of plasmin treated immune serum globulin for intravenous use. Sgouris JT Vox Sang; 1967 Jul; 13(1):71-84. PubMed ID: 4166592 [No Abstract] [Full Text] [Related]
38. Prevention of viral hepatitis. Grady GF Can Med Assoc J; 1972 Feb; 106(Spec Issue):Suppl:453-5. PubMed ID: 4111524 [No Abstract] [Full Text] [Related]
39. Recent progress in viral hepatitis; a significant local problem. Punyagupta S J Med Assoc Thai; 1971 Jan; 54(6):379-84. PubMed ID: 4109472 [No Abstract] [Full Text] [Related]
40. Antibody to Australia antigen: detection with a simple radioimmune assay, incidence in military populations, and role in the prevention of hepatitis B with gamma globulin. Ginsberg AL; Conrad ME; Bancroft WH; Ling CM; Overby LR J Lab Clin Med; 1973 Aug; 82(2):317-25. PubMed ID: 4124497 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]